Drug intelligence / Profile preview

Poliprotect

Development stage
Unknown
Lead developer
Aboca
Modality
Small Molecules
Administration
Oral
01

Overview

Poliprotect is a 100% natural synergistic molecular complex used as a mucosal protective agent, primarily for the relief of heartburn, epigastric pain, burning, gastroesophageal reflux disease (GERD), and functional dyspepsia[1][2][4][5]. It is not a pharmaceutical drug but a substance-based medical device composed of a polysaccharide fraction (from Aloe vera, Malva sylvestris, and Althaea officinalis), minerals (limestone and nahcolite), and a flavonoid fraction from Glycyrrhiza glabra and Matricaria recutita[1][5]. Its primary mechanism is the formation of a mucoadhesive, protective film that mimics physiological mucus to shield the gastroesophageal and gastric mucosa from aggressive factors like acid and bile, thus reducing irritation and mucosal damage[2][4]. The flavonoid fraction provides antioxidant protection, further reducing mucosal irritation[4]. Poliprotect is marketed in Europe as NeoBianacid. Clinical evidence, including randomized controlled trials, demonstrates that it is non-inferior to proton pump inhibitors like omeprazole for symptom relief in non-erosive reflux and functional heartburn, with an excellent safety profile and good tolerability in adults, children, pregnant, and breastfeeding women[1][3][5]. It does not alter the gut microbiota and can be used alone or in combination with anti-secretory drugs[5].

Brand names
Poliprotect
Other names
NeoBianacid

Beyond the preview

Go deeper on Poliprotect.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliprotect.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call